Centiva Capital’s Precigen PGEN Stock Holding History

Centiva Capital’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-19,499	Closed	-$96K	–	1469
2021 Q3	$96K	Buy	+19,499	New	+$112K	0.01%	1053
2020 Q2	–	Sell	-22,015	Closed	-$75K	–	777
2020 Q1	$75K	Buy	+22,015	New	+$95K	﹤0.01%	513

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Centiva Capital's PGEN Position: Q4 2021 in Review

Centiva Capital sold out of Precigen (PGEN) in Q4 2021, closing a stake of 19,499 shares — an estimated $96K sold.

Centiva Capital first reported a position in PGEN in Q1 2020 and held it in 2 quarters. The position peaked at $96K in Q3 2021. 168 funds tracked by Wall St. Rank hold PGEN as of Q4 2021.

Centiva Capital reported no remaining Precigen position as of Q4 2021 after selling out during the quarter.
Centiva Capital sold 19,499 Precigen shares in Q4 2021, an estimated $96K.
Centiva Capital first reported a position in Precigen in Q1 2020 and held it in 2 quarters.
Centiva Capital's Precigen position peaked at $96K in Q3 2021.
168 funds tracked by Wall St. Rank held Precigen as of Q4 2021.

Based on Centiva Capital's 13F filing for Q4 2021, filed 14 Feb 2022.